-
MAIA Biotechnology enrolls first patient in expansion of phase 2 clinical trial for ateganosine in advanced non─small cell lung cancer
11 Jul 2025 06:35 GMT
… opportunity: Non-small cell lung cancer represents one of the largest … for non-small cell lung cancer for patients that have … label, dose finding phase 2 clinical trial. It is the first … advanced non-small cell lung cancer patients receiving third line …
-
Anti-GPC3 Therapies Market Gains Traction with Key Players Advancing Pipeline for Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Gastric Cancer, and Others | DelveInsight
11 Jul 2025 00:14 GMT
… of a Phase I clinical trial for 225Ac-GPC3 (BAY … As data from ongoing clinical trials mature, particularly those evaluating … -Small Cell Lung Cancer Market
Non-Small Cell Lung Cancer Market Insights, … carcinoma-non-small-cell-lung-cancer-gastric-cancer-and- …
-
MAIA Biotechnology doses first patient in expansion of Phase II lung cancer trial
10 Jul 2025 17:37 GMT
… treating advanced non-small cell lung cancer (NSCLC).
This development signifies the … now open for the prestigious Clinical Trials Arena Excellence Awards - one …
-
Dr. Arjan Gower Receives Grant to Study Targeted Therapy for Early-Stage Lung Cancer
10 Jul 2025 06:29 GMT
… early-stage non-small cell lung cancer (NSCLC) with rare EGFR … help launch a multi-institutional clinical trial led by Dr. Gower … improve long-term outcomes.
Lung cancer is the leading cause of … care for many patients with lung cancer, but those with uncommon …
-
SETD2 suppresses tumorigenesis in a KRASG12C-driven lung cancer model and its catalytic activity is regulated by histone acetylation
09 Jul 2025 18:24 GMT
… deletion accelerates KRASG12C-driven lung cancer pathogenesis in vivo
Several … with indicated antibodies of lung tumors from KCP and KCP … these observations and previous lung cancer mouse modeling studies (22 … in a Phase I clinical trial as a therapeutic in …
-
KRAS Inhibitors Market Size Clinical Trials Patent Approved Drugs Sales Insight
09 Jul 2025 14:58 GMT
… Drugs In Clinical Trials
KRAS Inhibitor Clinical Trials Insight By … outcomes. Lung cancer, especially non small cell lung cancer (NSCLC … , with many clinical trials investigating KRAS G12C … inhibitors advance through clinical trials and receive regulatory …
-
Cizzle Bio Submits NIH Grant Proposal with Premier Research Institutions to Advance Biomarker Blood Test for Lung Cancer
09 Jul 2025 12:55 GMT
… — detecting lung cancer before symptoms appear. Lung cancer is the … accuracy across different lung cancer histological subtypes. A … D., senior consultant for clinical trials at Cizzle Bio. … treating late-stage lung cancer, an important consideration …
-
Silexion Therapeutics Announces Positive Results in Preclinical Study Demonstrating Significant SIL204 Efficacy in Human Lung Cancer Cell Lines
09 Jul 2025 12:30 GMT
… 2/3 clinical trial in Q2 2026 to … and around 30% of lung cancers. Lung cancer represents a particularly significant … SIL204 in colorectal and lung cancer applications, potential expansion … preclinical studies and initiate clinical trials; (ii) Silexion…
-
Oncogene Cancer Research Donates £10,425 To Support Groundbreaking Lung Cancer Research At The Institute Of Cancer Research
09 Jul 2025 06:04 GMT
… Huang Lab into oncogene-driven lung cancers.
Dr Paul Huang, … difficult-to-treat forms of lung cancer driven by genetic mutations.
… living with oncogene-driven lung cancers. We accelerate research by … and pushing for more clinical trials to open in the UK …
-
Updates from ASCO 2025 in Advanced Non‒Small Cell Lung Cancer
08 Jul 2025 19:49 GMT
… novel biomarkers into prospective clinical trials rather than relying solely … CNS end points in clinical trials rather than post-hoc … for advanced non-small cell lung cancer (aNSCLC). Abstract 8501. … ) advanced non-small cell lung cancer (NSCLC) after a third …
About
© 1995-2025